重新审视老年糖尿病患者基于共病的分类及其与衰弱、失能和5年死亡率的关系
该研究基于884名社区居住的老年糖尿病患者,用潜在类别分析(LCA)重新拟合11种共病,并与5年前的分类比较。结果复现出3个共病特征类别,其与衰弱、失能和5年死亡率的关系不同:心血管共病类与衰弱和死亡率升高相关,老年综合征类与衰弱和失能升高相关。
要点
- 老年糖尿病患者可复现3个共病特征类别,类1最健康、类2老年综合征多、类3心血管病多。
- 类3(心血管共病多)与衰弱和5年死亡率升高相关,但与失能无关。
- 类2(老年综合征多)与衰弱和失能升高相关,但与死亡率无关。
核心结论
- 在老年糖尿病患者中复现出3个具有不同共病特征的潜在类别,其与衰弱、失能和5年死亡率的关系复杂,可能需要修订当前分层目标设定和治疗选择的依据。
研究设计与样本
- 研究为基于美国国家社会生活、健康与老龄化项目(NSHAP)的子样本分析,纳入884名社区居住且诊断为糖尿病的老年人。
- 主要目标是用潜在类别分析(LCA)对11种共病拟合模型,比较2010-2011年与2005-2006年的LCA模型。
- 次要目标是评估识别出的类别与衰弱、失能和5年死亡率的关联。
主要发现
- 2005-2006年和2010-2011年的LCA均拟合出3个相似的共病特征:类1几乎全部共病率最低,类2肥胖、高血压、关节炎和尿失禁率最高,类3心肌梗死、充血性心力衰竭和卒中率较高。
- 与较健康的类1(类别概率=0.67)相比,心血管共病更 prevalent 的类3(0.09)衰弱和死亡率风险更高,但失能风险无差异。
- 老年综合征共病更 prevalent 的类2(0.24)衰弱和失能风险更高,但死亡率风险无差异。
关键数值与推荐
- 类1类别概率=0.67,类2=0.24,类3=0.09。
- 与类1相比,类3衰弱和死亡率风险更高但失能无差异;类2衰弱和失能风险更高但死亡率无差异。
临床怎么用
- 对老年糖尿病患者进行共病分类时,可区分以心血管病为主和以老年综合征为主的特征,前者更需关注衰弱和死亡风险,后者更需关注衰弱和失能风险。
- 当前分层目标设定和治疗选择依据可能需要根据共病类别与结局的复杂关系进行修订。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited research has been conducted to risk stratify older adults with diabetes. Our objective was to reexamine the 2005-2006 classification systems in participants who are now 5 years older. METHODS: We examined a subsample of 884 community-residing older adults with the diagnosis of diabetes from the National Social Life, Health, and Aging Project. The primary objective was to utilize a latent class analysis (LCA) to fit a model to 11 comorbidities, comparing the 2010-2011 LCA model to that of 2005-2006. The secondary objective was to evaluate the association of the identified classes with frailty, disability, and 5-year mortality. RESULTS: Both 2005-2006 LCA and the 2010-2011 LCA model fit 3 similar comorbidity profiles: Class 1 with the lowest rates of nearly all comorbidities, Class 2 had highest rates of obesity, hypertension, arthritis, and incontinence, and Class 3 had the higher rates of myocardial infarctions, congestive heart failure, and stroke. When compared to the healthier Class 1 (class probability = 0.67), participants with a comorbidity profile with more prevalent cardiovascular conditions (Class 3; 0.09) were at higher risk of frailty and mortality, but not disability; whereas participants with a comorbidity profile with more prevalent geriatric syndrome conditions (Class 2; 0.24) were at higher risk of frailty and disability, but not mortality. CONCLUSIONS: We reconfirmed 3 latent classes with distinct comorbidity profiles among older adults with diabetes. However, the complex relationships between comorbidity classes with frailty, disability, and mortality will likely require revision of the current rationale for stratified goal setting and treatment selection.
引用
- Leung V, Wroblewski K, Schumm LP, et al. Reexamining the Classification of Older Adults With Diabetes by Comorbidities and Exploring Relationships With Frailty, Disability, and 5-year Mortality. J Gerontol A Biol Sci Med Sci. 2021. PMID: 34003280. doi:10.1093/gerona/glab141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。